Playtex Breast Pump Recall Issued for Power Adapters Due to Shock Risk

Playtex has issued a recall for power adapters used with certain breast pump products, after determining that the adapters may loosen from the pump and pose a risk of electric shocks for users.

The Playtex breast pump recall was announced by the FDA on March 18, impacting certain Nurser Delux Double Electric Breast Pumps with AC/DC power adapters.

The manufacturer indicates that the casing on the adapters may become loose and possibly separate from the pump. Although no reports have been received of injuries or incidents, these problems could pose an electrical shock hazard.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

The recall includes Playtex Nurser Deluxe Double Electric Breast Pumps with serial numbers ranging between P12324-XXXX and P13205-XXXX and production code numbers ranging between 1241 and 1324. The adapters were sold exclusively with the purchase of the Playtex Nurser Deluxe Double Breast Pump.

The affected nursing pumps were manufactured by Energizer Personal Care, Playtex Manufacturing, Inc. of Sheldon Connecticut where they were sold nationwide at specialty stores and online retailers.

The agency encourages customers to be cautious of the products and if the user notices any signs that the adapter is coming loose they should stop using the product immediately and contact Playtex at 1-888-207-1429 or visit them online at www.playtexproducts.com.

Adverse events linked to the breast pumps can be submitted to the FDA’s MedWatch Adverse Event Reporting program.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Oxbryta Class Action Lawsuit Filed by Former Users of Sickle Cell Disease Drug Recalled in 2024
Oxbryta Class Action Lawsuit Filed by Former Users of Sickle Cell Disease Drug Recalled in 2024 (Posted today)

Former users of the recalled sickle cell disease drug Oxbryta have filed a class action lawsuit, claiming the manufacturer failed to warn consumers about risks associated with the medication, which can result in stroke and death.

Group of 20 Uber Driver Sexual Assault Lawsuits Will Be Prepared for Bellwether Trials in Dec. 2025
Group of 20 Uber Driver Sexual Assault Lawsuits Will Be Prepared for Bellwether Trials in Dec. 2025 (Posted today)

Plaintiffs and defendants have each been directed to select 10 Uber driver sexual assault lawsuits to serve as potential bellwether trials by February 14, 2025, which will then go through case-specific discovery to prepare for early test trials.

Pfizer Agrees Brain Tumor Lawsuits Over Depo-Provera Should Be Centralized in MDL
Pfizer Agrees Brain Tumor Lawsuits Over Depo-Provera Should Be Centralized in MDL (Posted 3 days ago)

Birth control shot manufacturer supports the consolidation of Depo-Provera brain tumor lawsuits, but argues that the claims should be centralized in the Southern District of New York, where the company is headquartered.